Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

In the spirit of reconciliation, Australian Associated Press acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our ...

In related news, Singapore-based pharmaceutical company Mirxes, which specializes in cancer treatment, also had a strong debut in Hong Kong on the same day. The company’s shares rose by 28% in morning ...

Singapore-based cancer diagnostics firm MiRXES has listed on the Hong Kong Stock Exchange, with shares jumping 24.5% above the HKD 23.3 offer price on debut. The stock was trading at HKD 30 as of 3:00 ...

Theodore Shou, CEO of Yiyi Capital, discusses the recent strong performance of the IPO market in Hong Kong and says that the valuation premium between mainland China and Hong Kong stocks would narrow ...

Indian markets opened higher, driven by ITC and IT stocks, but concerns over foreign fund outflows and the U.S. fiscal ...

Asian indexes traded higher on Friday as U.S. Treasury yields eased after a rocky week due to worries in the bond market over ...

The NYSE debut is the first major IPO for a venture-backed digital-health company since the pandemic-era boom. The top lender, advised by law firm Paul Weiss, is in discussions to take over the ...

The Chinese drugmaker raised HK$9.74 billion, equivalent to US$1.25 billion, in net proceeds, making it one of Hong Kong's largest IPOs so far this year. The stock was priced at HK$44.05 per share, ...

Shares of Jiangsu Hengrui Pharmaceuticals soared Friday morning, as more companies seek to tap Hong Kong’s capital markets.

Sany Heavy Industry has submitted a listing application to the Hong Kong Stock Exchange, naming CLSA as overall coordinator. No securities are currently being offered and that regulatory approval is ...

On the global front, Asian markets traded mostly higher today as investors assess a slew of economic data from the region.